These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25174926)

  • 1. Antagonists of IAP proteins: novel anti-tumor agents.
    Wan Y; Liu T; Hou X; Dun Y; Guan P; Fang H
    Curr Med Chem; 2014; 21(34):3877-92. PubMed ID: 25174926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of small-molecule Smac mimetics as IAP antagonists.
    Wang S
    Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
    Zhu H; Li Y; Liu Y; Han B
    ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.
    Cong H; Xu L; Wu Y; Qu Z; Bian T; Zhang W; Xing C; Zhuang C
    J Med Chem; 2019 Jun; 62(12):5750-5772. PubMed ID: 30676015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting the inhibitors: retro-inverso Smac peptides.
    Hossbach J; Michalsky E; Henklein P; Jaeger M; Daniel PT; Preissner R
    Peptides; 2009 Dec; 30(12):2374-9. PubMed ID: 19682522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists.
    Łupicka-Słowik A; Psurski M; Grzywa R; Cuprych M; Ciekot J; Goldeman W; Wojaczyńska E; Wojaczyński J; Oleksyszyn J; Sieńczyk M
    Invest New Drugs; 2020 Oct; 38(5):1350-1364. PubMed ID: 32270379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting XIAP for Promoting Cancer Cell Death-The Story of ARTS and SMAC.
    Abbas R; Larisch S
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting IAP proteins for therapeutic intervention in cancer.
    Fulda S; Vucic D
    Nat Rev Drug Discov; 2012 Feb; 11(2):109-24. PubMed ID: 22293567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide.
    Xiao XY; Jiang GS; Wang L; Lv L; Zeng FQ
    Anticancer Drugs; 2011 Oct; 22(9):853-63. PubMed ID: 21642838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
    Ali R; Singh S; Haq W
    Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).
    Rathore R; McCallum JE; Varghese E; Florea AM; Büsselberg D
    Apoptosis; 2017 Jul; 22(7):898-919. PubMed ID: 28424988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMAC-expression in denervated human skeletal muscle as a potential inhibitor of coexpressed inhibitor-of-apoptosis proteins.
    Tews DS; Behrhof W; Schindler S
    Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):66-70. PubMed ID: 18091317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
    Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
    Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.
    Cossu F; Malvezzi F; Canevari G; Mastrangelo E; Lecis D; Delia D; Seneci P; Scolastico C; Bolognesi M; Milani M
    Protein Sci; 2010 Dec; 19(12):2418-29. PubMed ID: 20954235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling of the regulation of caspase-3 activation and degradation.
    Stucki JW; Simon HU
    J Theor Biol; 2005 May; 234(1):123-31. PubMed ID: 15721041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
    Nachmias B; Ashhab Y; Ben-Yehuda D
    Semin Cancer Biol; 2004 Aug; 14(4):231-43. PubMed ID: 15219616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
    Smolewski P; Robak T
    Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.